Next Article in Journal
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms
Next Article in Special Issue
Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
Previous Article in Journal
Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain
Previous Article in Special Issue
Editorial: Surgical Advances in Pancreaticobiliary Diseases
 
 
Article

Article Versions Notes

J. Clin. Med. 2023, 12(4), 1353; https://doi.org/10.3390/jcm12041353
Action Date Notes Link
article xml file uploaded 8 February 2023 11:01 CET Original file -
article xml uploaded. 8 February 2023 11:01 CET Update https://www.mdpi.com/2077-0383/12/4/1353/xml
article pdf uploaded. 8 February 2023 11:01 CET Version of Record https://www.mdpi.com/2077-0383/12/4/1353/pdf
article supplementary file uploaded. 8 February 2023 11:01 CET - https://www.mdpi.com/2077-0383/12/4/1353#supplementary
article html file updated 8 February 2023 11:02 CET Original file -
article html file updated 1 March 2023 13:20 CET Update https://www.mdpi.com/2077-0383/12/4/1353/html
Back to TopTop